Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech Purchases HiSeq 2000 Instrument

Premium

This article was originally published Jan. 21.

German service provider GATC Biotech said last week that it has purchased an Illumina HiSeq 2000 sequencer for its Constance laboratory.

The company said in a statement that the new platform, which Illumina launched earlier this month (see In Sequence 1/12/2010), will initially be used for human genome sequencing projects from customers in pharmaceutical and medical research. In addition, GATC plans to offer services on the system to industrial and academic researchers interested in sequencing large eukaryotic genomes.

GATC Biotech CEO Peter Pohl said in a statement that the system, which will complement the firm's three existing Illumina Genome Analyzer IIx sequencers, will be "quickly installed and geared up for production."

The company also has several Roche GS FLX and Applied Biosystems 3730xl sequencers installed, and has been testing Complete Genomics' human genome sequencing service.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.